Stay updated with breaking news from Typei Interferons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have now discovered how the virus reactivates after lying dormant in the body. The findings could be important for long COVID research.
Once infected with a herpes virus, it lies dormant in the body, waiting for its next chance. Researchers have now discovered how the virus reactivates. This could also be important for Long-COVID research.
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...